Home › Idiopathic Hypersomnia › North Carolina
Pag-aaral pangklinika para sa Idiopathic Hypersomnia sa North Carolina
7 pag-aaral para sa Idiopathic Hypersomnia ang naghahanap ng mga kalahok sa mga site sa North Carolina.
Mga Lungsod sa North Carolina
Opisyal na teksto ng pag-aaral (English)
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Research Carolina Elite LLC, Denver
- Clinical Research of Gastonia, Gastonia
- David Kudrow, MD, Morrisville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07500090A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Takeda Site 24, Denver
- Takeda Site 10, Huntersville
- Takeda Site 22, Winston-Salem
Nagre-recruitPhase 2/3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07646678A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Denver
- Alkermes Investigational Site, Huntersville
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06767683A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Research Carolina Elite, Denver
- Science 37, Morrisville
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07625280A Study of TAK-360 in Adults With Idiopathic Hypersomnia
- Takeda Site 16, Denver
- Takeda Site 15, Huntersville
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06812078A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Denver, North Carolina, Denver
- Huntersville, North Carolina, Huntersville
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06752668A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Denver, North Carolina, Denver
- Huntersville, North Carolina, Huntersville
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07096674Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.